When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Aggressive fibromatosis - Wikipedia

    en.wikipedia.org/wiki/Aggressive_fibromatosis

    A subcategory of D48.1, Neoplasm of uncertain behavior of connective and other soft tissue, has been created with more specific codes: [50] D48.11: Desmoid tumor D48.110: Desmoid tumor of head and neck; D48.111: Desmoid tumor of chest wall; D48.112: Desmoid tumor, intrathoracic; D48.113: Desmoid tumor of abdominal wall

  3. List of ICD-9 codes 140–239: neoplasms - Wikipedia

    en.wikipedia.org/wiki/List_of_ICD-9_codes_140...

    236 Neoplasm of uncertain behavior of genitourinary organs; 237 Neoplasm of uncertain behavior of endocrine glands and nervous system. 237.0 Pituitary gland and craniopharyngeal duct. Pituitary adenoma; 237.7 Neurofibromatosis; 238 Neoplasm of uncertain behavior of other and unspecified sites and tissues 238.4 Polycythemia vera

  4. Neoplasm - Wikipedia

    en.wikipedia.org/wiki/Neoplasm

    [3] [4] [5] This abnormal growth usually forms a mass, which may be called a tumour or tumor. [6] ICD-10 classifies neoplasms into four main groups: benign neoplasms, in situ neoplasms, malignant neoplasms, and neoplasms of uncertain or unknown behavior. [7] Malignant neoplasms are also simply known as cancers and are the focus of oncology.

  5. M8000/9 Neoplasm, malignant, uncertain whether primary or metastatic. Unclassified tumor, malignant, uncertain whether primary or metastatic; M8001/0 Tumor cells, benign.

  6. Melanocytic tumors of uncertain malignant potential - Wikipedia

    en.wikipedia.org/wiki/Melanocytic_tumors_of...

    A related category of melanocytic proliferation is superficial atypical melanocytic proliferations of uncertain significance (SAMPUS). This category, unlike MELTUMP, which implies as yet undetermined potential for metastases even after complete excision, signifies lesions without metastatic potential at time of excision but with potential to ...

  7. Neuroendocrine tumor - Wikipedia

    en.wikipedia.org/wiki/Neuroendocrine_tumor

    Although estimates vary, the annual incidence of clinically significant neuroendocrine tumors is approximately 2.55 per 100,000; [103] two thirds are carcinoid tumors and one third are other NETs. The prevalence has been estimated as 35 per 100,000, [ 103 ] and may be considerably higher if clinically silent tumors are included.

  8. Hematological malignancies are malignant neoplasms ("cancer"), and they are generally treated by specialists in hematology and/or oncology. In some centers "hematology/oncology" is a single subspecialty of internal medicine while in others they are considered separate divisions (there are also surgical and radiation oncologists).

  9. Smooth muscle tumor of uncertain malignant potential

    en.wikipedia.org/wiki/Smooth_muscle_tumor_of...

    No or mild atypia, no tumor cell necrosis ⇒ leiomyoma. If 5 or more mitotic figures are present in 10 high powered fields but the behavior still appears benign, may append “with significant mitotic activity”. Moderate to severe atypia without tumor cell necrosis atypical leiomyoma if < 10 mitotic figures per high power field or